Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 166.60% | 155.79% | 142.69% | 123.71% | 89.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 166.60% | 155.79% | 142.69% | 123.71% | 89.63% |
| Cost of Revenue | 299.44% | 282.37% | 261.82% | 200.04% | 121.36% |
| Gross Profit | 124.75% | 117.80% | 108.80% | 102.13% | 81.45% |
| SG&A Expenses | 23.96% | 31.77% | 34.50% | 29.92% | 16.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.23% | 54.53% | 52.50% | 41.94% | 22.37% |
| Operating Income | 33.46% | 11.06% | -2.39% | -3.45% | 3.31% |
| Income Before Tax | 18.55% | -1.00% | -8.11% | 2.01% | 8.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.55% | -1.00% | -8.11% | 2.01% | 8.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.55% | -1.00% | -8.11% | 2.01% | 8.24% |
| EBIT | 33.46% | 11.06% | -2.39% | -3.45% | 3.31% |
| EBITDA | 35.80% | 13.56% | 0.15% | -1.14% | 4.78% |
| EPS Basic | 21.13% | 2.34% | -3.51% | 8.02% | 14.79% |
| Normalized Basic EPS | 25.14% | 7.67% | 1.77% | 2.56% | 10.03% |
| EPS Diluted | 21.13% | 2.34% | -3.51% | 8.02% | 14.79% |
| Normalized Diluted EPS | 25.14% | 7.67% | 1.77% | 2.56% | 10.03% |
| Average Basic Shares Outstanding | 3.15% | 3.50% | 4.16% | 6.37% | 7.38% |
| Average Diluted Shares Outstanding | 3.15% | 3.50% | 4.16% | 6.37% | 7.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |